Transcriptional expression and gelatinolytic activity of matrix metalloproteinases in Henoch-Schonlein purpura

Aim:  Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several rheumatological disorders and systemic vasculitides, especially Takayasu’s arteritis and Kawasaki disease. Therefore, the aim of the present study was...

Full description

Saved in:
Bibliographic Details
Published inActa Paediatrica Vol. 99; no. 8; pp. 1248 - 1252
Main Authors Mahajan, N, Bisht, D, Dhawan, V, Singh, S, Minz, RW
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.08.2010
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Aim:  Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several rheumatological disorders and systemic vasculitides, especially Takayasu’s arteritis and Kawasaki disease. Therefore, the aim of the present study was to investigate the potential role of MMPs in Henoch–Schonlein purpura (HSP), an acute type of systemic vasculitis in children. Methods:  We studied the activity of MMP‐2 and MMP‐9 in the sera using gelatin zymography and the transcriptional expression in peripheral blood mononuclear cells using semi‐quantitative RT‐PCR in 20 patients with HSP in acute and convalescent phase and in 20 healthy children, who were siblings of the subjects with same age group. Results:  All 20 children with HSP showed increased levels of serum activity of MMP‐2 and MMP‐9 in acute phase as compared with their convalescent phase [MMP‐2 (p > 0.05); MMP‐9 (p > 0.05)] and their control counterparts [MMP‐2 (p < 0.001); MMP‐9 (p < 0.001)]. Similarly, transcriptional expression of MMPs was found to be higher in the acute phase of HSP than in convalescent phase [MMP‐2 (p < 0.05); MMP‐9 (p < 0.001)] and in their healthy controls [MMP‐2 (p < 0.001); MMP‐9 (p < 0.01)]. Conclusion:  The presence of excessive transcriptional expression and gelatinolytic activity of MMPs may be downstream to the actual aetiopathogenetic factors.
AbstractList Aim:  Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several rheumatological disorders and systemic vasculitides, especially Takayasu’s arteritis and Kawasaki disease. Therefore, the aim of the present study was to investigate the potential role of MMPs in Henoch–Schonlein purpura (HSP), an acute type of systemic vasculitis in children. Methods:  We studied the activity of MMP‐2 and MMP‐9 in the sera using gelatin zymography and the transcriptional expression in peripheral blood mononuclear cells using semi‐quantitative RT‐PCR in 20 patients with HSP in acute and convalescent phase and in 20 healthy children, who were siblings of the subjects with same age group. Results:  All 20 children with HSP showed increased levels of serum activity of MMP‐2 and MMP‐9 in acute phase as compared with their convalescent phase [MMP‐2 (p > 0.05); MMP‐9 (p > 0.05)] and their control counterparts [MMP‐2 (p < 0.001); MMP‐9 (p < 0.001)]. Similarly, transcriptional expression of MMPs was found to be higher in the acute phase of HSP than in convalescent phase [MMP‐2 (p < 0.05); MMP‐9 (p < 0.001)] and in their healthy controls [MMP‐2 (p < 0.001); MMP‐9 (p < 0.01)]. Conclusion:  The presence of excessive transcriptional expression and gelatinolytic activity of MMPs may be downstream to the actual aetiopathogenetic factors.
Abstract Aim:  Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several rheumatological disorders and systemic vasculitides, especially Takayasu’s arteritis and Kawasaki disease. Therefore, the aim of the present study was to investigate the potential role of MMPs in Henoch–Schonlein purpura (HSP), an acute type of systemic vasculitis in children. Methods:  We studied the activity of MMP‐2 and MMP‐9 in the sera using gelatin zymography and the transcriptional expression in peripheral blood mononuclear cells using semi‐quantitative RT‐PCR in 20 patients with HSP in acute and convalescent phase and in 20 healthy children, who were siblings of the subjects with same age group. Results:  All 20 children with HSP showed increased levels of serum activity of MMP‐2 and MMP‐9 in acute phase as compared with their convalescent phase [MMP‐2 (p > 0.05); MMP‐9 (p > 0.05)] and their control counterparts [MMP‐2 (p < 0.001); MMP‐9 (p < 0.001)]. Similarly, transcriptional expression of MMPs was found to be higher in the acute phase of HSP than in convalescent phase [MMP‐2 (p < 0.05); MMP‐9 (p < 0.001)] and in their healthy controls [MMP‐2 (p < 0.001); MMP‐9 (p < 0.01)]. Conclusion:  The presence of excessive transcriptional expression and gelatinolytic activity of MMPs may be downstream to the actual aetiopathogenetic factors.
Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several rheumatological disorders and systemic vasculitides, especially Takayasu's arteritis and Kawasaki disease. Therefore, the aim of the present study was to investigate the potential role of MMPs in Henoch-Schonlein purpura (HSP), an acute type of systemic vasculitis in children. We studied the activity of MMP-2 and MMP-9 in the sera using gelatin zymography and the transcriptional expression in peripheral blood mononuclear cells using semi-quantitative RT-PCR in 20 patients with HSP in acute and convalescent phase and in 20 healthy children, who were siblings of the subjects with same age group. All 20 children with HSP showed increased levels of serum activity of MMP-2 and MMP-9 in acute phase as compared with their convalescent phase [MMP-2 (p > 0.05); MMP-9 (p > 0.05)] and their control counterparts [MMP-2 (p < 0.001); MMP-9 (p < 0.001)]. Similarly, transcriptional expression of MMPs was found to be higher in the acute phase of HSP than in convalescent phase [MMP-2 (p < 0.05); MMP-9 (p < 0.001)] and in their healthy controls [MMP-2 (p < 0.001); MMP-9 (p < 0.01)]. The presence of excessive transcriptional expression and gelatinolytic activity of MMPs may be downstream to the actual aetiopathogenetic factors.
AbstractAim: Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several rheumatological disorders and systemic vasculitides, especially Takayasu's arteritis and Kawasaki disease. Therefore, the aim of the present study was to investigate the potential role of MMPs in Henoch-Schonlein purpura (HSP), an acute type of systemic vasculitis in children.Methods: We studied the activity of MMP-2 and MMP-9 in the sera using gelatin zymography and the transcriptional expression in peripheral blood mononuclear cells using semi-quantitative RT-PCR in 20 patients with HSP in acute and convalescent phase and in 20 healthy children, who were siblings of the subjects with same age group.Results: All 20 children with HSP showed increased levels of serum activity of MMP-2 and MMP-9 in acute phase as compared with their convalescent phase [MMP-2 (p > 0.05); MMP-9 (p > 0.05)] and their control counterparts [MMP-2 (p < 0.001); MMP-9 (p < 0.001)]. Similarly, transcriptional expression of MMPs was found to be higher in the acute phase of HSP than in convalescent phase [MMP-2 (p < 0.05); MMP-9 (p < 0.001)] and in their healthy controls [MMP-2 (p < 0.001); MMP-9 (p < 0.01)].Conclusion: The presence of excessive transcriptional expression and gelatinolytic activity of MMPs may be downstream to the actual aetiopathogenetic factors.
AIMAccelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several rheumatological disorders and systemic vasculitides, especially Takayasu's arteritis and Kawasaki disease. Therefore, the aim of the present study was to investigate the potential role of MMPs in Henoch-Schonlein purpura (HSP), an acute type of systemic vasculitis in children.METHODSWe studied the activity of MMP-2 and MMP-9 in the sera using gelatin zymography and the transcriptional expression in peripheral blood mononuclear cells using semi-quantitative RT-PCR in 20 patients with HSP in acute and convalescent phase and in 20 healthy children, who were siblings of the subjects with same age group.RESULTSAll 20 children with HSP showed increased levels of serum activity of MMP-2 and MMP-9 in acute phase as compared with their convalescent phase [MMP-2 (p > 0.05); MMP-9 (p > 0.05)] and their control counterparts [MMP-2 (p < 0.001); MMP-9 (p < 0.001)]. Similarly, transcriptional expression of MMPs was found to be higher in the acute phase of HSP than in convalescent phase [MMP-2 (p < 0.05); MMP-9 (p < 0.001)] and in their healthy controls [MMP-2 (p < 0.001); MMP-9 (p < 0.01)].CONCLUSIONThe presence of excessive transcriptional expression and gelatinolytic activity of MMPs may be downstream to the actual aetiopathogenetic factors.
Author Bisht, D
Minz, RW
Dhawan, V
Singh, S
Mahajan, N
Author_xml – sequence: 1
  givenname: N
  surname: Mahajan
  fullname: Mahajan, N
  organization: Department of Experimental Medicine and Biotechnology, Research Block 'B', Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh, India
– sequence: 2
  givenname: D
  surname: Bisht
  fullname: Bisht, D
  organization: Advanced Pediatric Center, Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh, India
– sequence: 3
  givenname: V
  surname: Dhawan
  fullname: Dhawan, V
  organization: Department of Experimental Medicine and Biotechnology, Research Block 'B', Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh, India
– sequence: 4
  givenname: S
  surname: Singh
  fullname: Singh, S
  organization: Advanced Pediatric Center, Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh, India
– sequence: 5
  givenname: RW
  surname: Minz
  fullname: Minz, RW
  organization: Department of Immunopathology, Research Block 'A', Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh, India
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22946876$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20337780$$D View this record in MEDLINE/PubMed
BookMark eNqNkVGPEyEQx4k54_VOv4Lhxfi0FZZlFx58qBftXdKoiaeX-EJYOutRWbYC9bbfXtbW-qiEhGH4_YfJ_C_QmR88IIQpmdO8Xm3mtOa0KMuymZckZwltBJ2Pj9Ds9HCGZkQQVvCSs3N0EeOGkJLJqn6CzkvCWNMIMkP-NmgfTbDbZAevHYZxGyDGfMHar_E3cDpZP7h9sgZrk-xPm_Z46HCvU7Aj7iFp54ZtGBJYryNEbD2-Bj-Y--KTuR-8y3m83YW89VP0uNMuwrPjeYk-v3t7e3VdrD4sb64Wq8JUtaBFJ9ZdBVS2FVtz4BXTQFsJjZS85kSYumO8lgKEaWlrpCZcGtowQlhFjaw0u0QvD3VzXz92EJPqbTTgnPYw7KJqqrpkXHD6b5IxLnNpkUlxIE0YYgzQqW2wvQ57RYmabFEbNU1fTdNXky3qty1qzNLnx092bQ_rk_CPDxl4cQR0NNp12RRj41-uzL6Jps7c6wP3YB3s_7sBtfi4mKKsLw56GxOMJ70O31XdsIaru_dL9aWqV3fLr29UxX4BzTu7MQ
CitedBy_id crossref_primary_10_1016_j_avsg_2016_02_011
crossref_primary_10_3109_0886022X_2012_757826
crossref_primary_10_1586_1744666X_2013_850028
crossref_primary_10_1007_s11010_017_2953_9
crossref_primary_10_1111_pde_12222
crossref_primary_10_1007_s13312_013_0020_5
crossref_primary_10_1155_2014_827105
Cites_doi 10.1136/ard.2005.046300
10.1002/art.1780391019
10.1046/j.1365-2249.2001.01608.x
10.1046/j.1523-1755.2003.00939.x
10.1111/j.1745-7270.2008.00418.x
10.1016/j.bcp.2007.07.004
10.1007/s00467-003-1292-0
10.1080/03009740510026940
10.1016/j.ijcard.2009.09.557
10.1007/s00296-008-0800-8
10.1161/01.CIR.98.3.193
10.1016/B978-1-4160-0246-8.50029-2
10.1016/0003-2697(76)90527-3
10.1042/cs0810233
10.1002/jcla.20024
ContentType Journal Article
Copyright 2010 The Author(s)/Journal Compilation © 2010 Foundation Acta Pædiatrica
2015 INIST-CNRS
Copyright_xml – notice: 2010 The Author(s)/Journal Compilation © 2010 Foundation Acta Pædiatrica
– notice: 2015 INIST-CNRS
DBID BSCLL
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7TM
DOI 10.1111/j.1651-2227.2010.01781.x
DatabaseName Istex
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
Nucleic Acids Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
Nucleic Acids Abstracts
DatabaseTitleList
CrossRef
MEDLINE
Nucleic Acids Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1651-2227
EndPage 1252
ExternalDocumentID 10_1111_j_1651_2227_2010_01781_x
20337780
22946876
APA1781
ark_67375_WNG_V46LWGZB_4
Genre article
Journal Article
GroupedDBID .55
.GA
.GJ
1OC
3O-
51W
51X
52N
52O
52P
52R
52T
52W
52X
53G
5GY
5HH
5LA
5RE
66C
7PT
930
A01
A03
AAWTL
ABDBF
ACGFS
AI.
ALMA_UNASSIGNED_HOLDINGS
BSCLL
BY8
EAD
EAP
EAS
EBC
EBD
EBX
EMB
EMK
EMOBN
EPT
ESX
F5P
LP6
LP7
N9D
P4B
P4D
Q~Q
SV3
TUS
VH1
WQJ
WRC
WXI
X7M
ZGI
.3N
.Y3
05W
08R
0R~
10A
1OB
31~
33P
36B
3SF
4.4
50Y
50Z
52M
52S
52U
52V
5VS
702
8-0
8-1
8-3
8-4
8-5
8UM
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AAQQT
AASGY
AAUGY
AAVGM
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABHUG
ABIVO
ABLJU
ABPTK
ABPVW
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGEJ
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACSMX
ACXBN
ACXME
ACXQS
ADAWD
ADBBV
ADBTR
ADDAD
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXPE
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFGKR
AFPWT
AFRAH
AFVGU
AFZJQ
AGJLS
AHEFC
AHMBA
AIACR
AIURR
AIWBW
AJBDE
AJWEG
ALAGY
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DUUFO
EBS
EJD
EX3
F00
F01
F04
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HZ~
IQODW
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OVD
P2W
P2X
P2Z
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WUP
WVDHM
WXSBR
XG1
ZA5
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7TM
ABJNI
ABQWH
AFFPM
AHBTC
AITYG
HGLYW
HVGLF
OIG
ID FETCH-LOGICAL-c4681-f8df4e19b43d5e543ae1b9e79956508c6f35698e8cb1bc9a059c17300341c94a3
IEDL.DBID DR2
ISSN 0803-5253
IngestDate Sat Aug 17 01:13:47 EDT 2024
Fri Oct 25 09:42:43 EDT 2024
Fri Aug 23 02:01:10 EDT 2024
Sat Sep 28 08:01:29 EDT 2024
Sun Oct 22 16:06:41 EDT 2023
Sat Aug 24 00:55:27 EDT 2024
Wed Oct 30 09:59:57 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Pediatrics
Matrix metalloprotienases
Skin disease
Transcription
Enzyme
Transcriptional expression
Diseases of the osteoarticular system
Cardiovascular disease
Metalloendopeptidases
Henoch-Schonlein purpura
Gene expression
Biological activity
Vascular disease
Peptidases
Henoch-Schönlein purpura
Hydrolases
Capillary vessel disease
Zymography
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4681-f8df4e19b43d5e543ae1b9e79956508c6f35698e8cb1bc9a059c17300341c94a3
Notes ArticleID:APA1781
ark:/67375/WNG-V46LWGZB-4
istex:EA7F72BAE07785E02911FB9B1A46203EDA3485D4
These authors contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 20337780
PQID 733597308
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_746235851
proquest_miscellaneous_733597308
crossref_primary_10_1111_j_1651_2227_2010_01781_x
pubmed_primary_20337780
pascalfrancis_primary_22946876
wiley_primary_10_1111_j_1651_2227_2010_01781_x_APA1781
istex_primary_ark_67375_WNG_V46LWGZB_4
PublicationCentury 2000
PublicationDate August 2010
PublicationDateYYYYMMDD 2010-08-01
PublicationDate_xml – month: 08
  year: 2010
  text: August 2010
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: Norway
PublicationTitle Acta Paediatrica
PublicationTitleAlternate Acta Paediatr
PublicationYear 2010
Publisher Blackwell Publishing Ltd
Blackwell
Publisher_xml – name: Blackwell Publishing Ltd
– name: Blackwell
References Bagga A, Kabra SK, Shrivastva RN, Bhuyan UN. Henoch-Schonlein Purpura in Northern Indian Children. Indian J Pediatr 1991; 28: 1153-7.
Kumar L, Singh S, Goraya JS, Uppal B, Kakkar S, Walker R, et al. Henoch-Schonlein purpura: The Chandigarh Experience. Indian J Pediatr 1998; 35: 19-27.
Sorbi D, French DL, Nuovo GJ, Kew RR, Arbeit LA, Gruber BL. Elevated levels of 92-kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis. Arthritis Rheum 1996; 39: 1747-53.
Davies MJ. Aortic aneurysm formation: lessons from human studies and experimental models. Circulation 1998; 98: 193-195.
Zou CC, Zhao ZY, Tang LF, Liang L. Plasma levels of matrix metalloproteinase-9 in Henoch- Schönlein purpura. Scand J Rheumatol 2006; 35: 52-5.
Tashiro K, Koyanagi I, Ohara I, Ito T, Saitoh A, Horikoshi S, et al. Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy. J Clin Lab Anal 2004; 18: 206-10.
Mahajan N, Dhawan V, Malik S, Jain S. Implication of oxidative stress and its correlation with activity of matrix metalloproteinases in patients with Takayasu's Arteritis disease. Int J Cardiol 2009; doi: 10.1016/j.ijcard.2009.09.557.
Ozen S, Ruperto N, Dillon MJ. EULAR/PreS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006; 65: 936-41.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
Nikkari ST, Hoyhtya M, Isola J, Nikkari T. Macrophages contain 92-KD gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis. Am J Pathol 1996; 149: 1427-33.
Takeshita S, Tokutomi T, Kawasae H, Nakatani K, Tsujimoto H, Kamamura Y, et al. Elevated serum levels of matrix metalloproteinase-9 (MMP 9) in Kawasaki disease. Clin Exp Immunol 2001; 125: 340-4.
Rao VH, Lees GE, Kashtan CE, Nemori R, Singh RK, Meehan DT. Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS). Kidney Int 2003; 63: 1736-48.
Vine N, Powell JT. Metalloproteinases in degenerative aortic disease. Clin Sci 1991; 816: 233-9.
Guo Y, Peng X, Lei S. How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochim Biophys Sin 2008; 40: 426-36.
Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008; 75: 346-59.
Chua PK, Meish ME, Yu Q, Yanagihara R, Yamamoto KS, Nerurkar VR. Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease. Clin Diagn Lab Immunol 2003; 110: 308-14.
Davin JC, Weening JJ. Diagnosis of Henoch-Schonlein purpura: renal or skin biopsy? Pediatr Nephrol 2003; 18: 1201-3.
Mahajan N, Dhawan V. C-reactive protein (CRP) - induced up-regulation of MMPs and their tissue inhibitor in THP-1cells: Inhibitory effects of Atorvastatin. Mol Cell Biochem. doi: 10.1007/s11010-009-0340-x.
Mahajan V, Singh S, Khullar M, Minz RW. Serum and urine nitric oxide levels in children with Henoch-Schonlein purpura during activity and remission: a study from North India. Rheumatol Int 2009; 29: 1069-72.
1991; 28
1996; 39
2004; 18
2006; 35
2006; 65
1976; 72
2009
1991; 816
2005
2004
2003; 18
2008; 75
2008; 40
1998; 98
2003; 63
2001; 125
2003; 110
2009; 29
1998; 35
1996; 149
e_1_2_7_3_2
Bagga A (e_1_2_7_5_2) 1991; 28
e_1_2_7_8_2
e_1_2_7_7_2
e_1_2_7_6_2
e_1_2_7_19_2
Kumar L (e_1_2_7_4_2) 1998; 35
e_1_2_7_18_2
e_1_2_7_17_2
e_1_2_7_16_2
e_1_2_7_15_2
Miller ML (e_1_2_7_2_2) 2004
e_1_2_7_13_2
e_1_2_7_12_2
e_1_2_7_11_2
e_1_2_7_22_2
e_1_2_7_21_2
e_1_2_7_20_2
Mahajan N (e_1_2_7_14_2)
Nikkari ST (e_1_2_7_10_2) 1996; 149
Chua PK (e_1_2_7_9_2) 2003; 110
References_xml – volume: 28
  start-page: 1153
  year: 1991
  end-page: 7
  article-title: Henoch–Schonlein Purpura in Northern Indian Children
  publication-title: Indian J Pediatr
– volume: 65
  start-page: 936
  year: 2006
  end-page: 41
  article-title: EULAR/PreS endorsed consensus criteria for the classification of childhood vasculitides
  publication-title: Ann Rheum Dis
– volume: 18
  start-page: 206
  year: 2004
  end-page: 10
  article-title: Levels of urinary matrix metalloproteinase‐9 (MMP‐9) and renal injuries in patients with type 2 diabetic nephropathy
  publication-title: J Clin Lab Anal
– year: 2009
  article-title: Implication of oxidative stress and its correlation with activity of matrix metalloproteinases in patients with Takayasu’s Arteritis disease
  publication-title: Int J Cardiol
– article-title: C‐reactive protein (CRP) – induced up‐regulation of MMPs and their tissue inhibitor in THP‐1cells: Inhibitory effects of Atorvastatin
  publication-title: Mol Cell Biochem
– volume: 40
  start-page: 426
  year: 2008
  end-page: 36
  article-title: How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes
  publication-title: Acta Biochim Biophys Sin
– volume: 149
  start-page: 1427
  year: 1996
  end-page: 33
  article-title: Macrophages contain 92‐KD gelatinase (MMP‐9) at the site of degenerated internal elastic lamina in temporal arteritis
  publication-title: Am J Pathol
– volume: 110
  start-page: 308
  year: 2003
  end-page: 14
  article-title: Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease
  publication-title: Clin Diagn Lab Immunol
– volume: 29
  start-page: 1069
  year: 2009
  end-page: 72
  article-title: Serum and urine nitric oxide levels in children with Henoch–Schonlein purpura during activity and remission: a study from North India
  publication-title: Rheumatol Int
– volume: 75
  start-page: 346
  year: 2008
  end-page: 59
  article-title: Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease
  publication-title: Biochem Pharmacol
– volume: 125
  start-page: 340
  year: 2001
  end-page: 4
  article-title: Elevated serum levels of matrix metalloproteinase‐9 (MMP 9) in Kawasaki disease
  publication-title: Clin Exp Immunol
– volume: 35
  start-page: 52
  year: 2006
  end-page: 5
  article-title: Plasma levels of matrix metalloproteinase‐9 in Henoch‐ Schönlein purpura
  publication-title: Scand J Rheumatol
– volume: 816
  start-page: 233
  year: 1991
  end-page: 9
  article-title: Metalloproteinases in degenerative aortic disease
  publication-title: Clin Sci
– volume: 98
  start-page: 193
  year: 1998
  end-page: 195
  article-title: Aortic aneurysm formation: lessons from human studies and experimental models
  publication-title: Circulation
– volume: 18
  start-page: 1201
  year: 2003
  end-page: 3
  article-title: Diagnosis of Henoch–Schonlein purpura: renal or skin biopsy?
  publication-title: Pediatr Nephrol
– volume: 72
  start-page: 248
  year: 1976
  end-page: 54
  article-title: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein‐dye binding
  publication-title: Anal Biochem
– start-page: 496
  year: 2005
  end-page: 511
– volume: 35
  start-page: 19
  year: 1998
  end-page: 27
  article-title: Henoch–Schonlein purpura: The Chandigarh Experience
  publication-title: Indian J Pediatr
– start-page: 826
  year: 2004
  end-page: 30
– volume: 39
  start-page: 1747
  year: 1996
  end-page: 53
  article-title: Elevated levels of 92‐kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis
  publication-title: Arthritis Rheum
– volume: 63
  start-page: 1736
  year: 2003
  end-page: 48
  article-title: Increased expression of MMP‐2, MMP‐9 (type IV collagenases/gelatinases), and MT1‐MMP in canine X‐linked Alport syndrome (XLAS)
  publication-title: Kidney Int
– ident: e_1_2_7_12_2
  doi: 10.1136/ard.2005.046300
– ident: e_1_2_7_7_2
  doi: 10.1002/art.1780391019
– ident: e_1_2_7_8_2
  doi: 10.1046/j.1365-2249.2001.01608.x
– volume: 28
  start-page: 1153
  year: 1991
  ident: e_1_2_7_5_2
  article-title: Henoch–Schonlein Purpura in Northern Indian Children
  publication-title: Indian J Pediatr
  contributor:
    fullname: Bagga A
– ident: e_1_2_7_19_2
  doi: 10.1046/j.1523-1755.2003.00939.x
– ident: e_1_2_7_22_2
  doi: 10.1111/j.1745-7270.2008.00418.x
– ident: e_1_2_7_6_2
  doi: 10.1016/j.bcp.2007.07.004
– volume: 110
  start-page: 308
  year: 2003
  ident: e_1_2_7_9_2
  article-title: Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease
  publication-title: Clin Diagn Lab Immunol
  contributor:
    fullname: Chua PK
– ident: e_1_2_7_16_2
  doi: 10.1007/s00467-003-1292-0
– volume: 35
  start-page: 19
  year: 1998
  ident: e_1_2_7_4_2
  article-title: Henoch–Schonlein purpura: The Chandigarh Experience
  publication-title: Indian J Pediatr
  contributor:
    fullname: Kumar L
– ident: e_1_2_7_14_2
  article-title: C‐reactive protein (CRP) – induced up‐regulation of MMPs and their tissue inhibitor in THP‐1cells: Inhibitory effects of Atorvastatin
  publication-title: Mol Cell Biochem
  contributor:
    fullname: Mahajan N
– ident: e_1_2_7_17_2
  doi: 10.1080/03009740510026940
– volume: 149
  start-page: 1427
  year: 1996
  ident: e_1_2_7_10_2
  article-title: Macrophages contain 92‐KD gelatinase (MMP‐9) at the site of degenerated internal elastic lamina in temporal arteritis
  publication-title: Am J Pathol
  contributor:
    fullname: Nikkari ST
– start-page: 826
  volume-title: Nelson textbook of pediatrics
  year: 2004
  ident: e_1_2_7_2_2
  contributor:
    fullname: Miller ML
– ident: e_1_2_7_11_2
  doi: 10.1016/j.ijcard.2009.09.557
– ident: e_1_2_7_15_2
  doi: 10.1007/s00296-008-0800-8
– ident: e_1_2_7_21_2
  doi: 10.1161/01.CIR.98.3.193
– ident: e_1_2_7_3_2
  doi: 10.1016/B978-1-4160-0246-8.50029-2
– ident: e_1_2_7_13_2
  doi: 10.1016/0003-2697(76)90527-3
– ident: e_1_2_7_20_2
  doi: 10.1042/cs0810233
– ident: e_1_2_7_18_2
  doi: 10.1002/jcla.20024
SSID ssj0023946
ssj0004374
Score 2.014819
Snippet Aim:  Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several...
Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several rheumatological...
Abstract Aim:  Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several...
AIMAccelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several...
AbstractAim: Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several...
SourceID proquest
crossref
pubmed
pascalfrancis
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 1248
SubjectTerms Biological and medical sciences
Case-Control Studies
Child
Child, Preschool
Dermatology
Female
Gelatin - metabolism
General aspects
Henoch-Schonlein purpura
Humans
Male
Matrix Metalloproteinase 2 - metabolism
Matrix Metalloproteinase 9 - metabolism
Matrix metalloprotienases
Medical sciences
Purpura, Schoenlein-Henoch - blood
Purpura, Schoenlein-Henoch - enzymology
Reverse Transcriptase Polymerase Chain Reaction
Siblings
Transcription, Genetic
Transcriptional expression
Vascular disorders of the skin
Zymography
Title Transcriptional expression and gelatinolytic activity of matrix metalloproteinases in Henoch-Schonlein purpura
URI https://api.istex.fr/ark:/67375/WNG-V46LWGZB-4/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1651-2227.2010.01781.x
https://www.ncbi.nlm.nih.gov/pubmed/20337780
https://search.proquest.com/docview/733597308
https://search.proquest.com/docview/746235851
Volume 99
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1baxQxFA5SQXzxfhkvJQ_i2yyTyWWSx63aLmKLiLXFl5BkM7Vsm1n2Aluf_A_-Q3-JOZnZrSNFRHwbmEkgJ9_JOZl85wtCL2LEBp20Ivel4DkzzOWAm9wVyqlSVEwkMub-gRgdsrfH_LjjP0EtTKsPsfnhBp6R1mtwcGPnfScXnORQy9kxtEglyQDySUIrYHe9_nCpJMUopDndRoyqtoBHFjRuxDjtM3yu7LUXtq7DDKyARmnm0ZJ1ewXGVTlqP-VNMWv3NpqsR9tSVSaD5cIO3NffhCD_jznuoFtdaouHLRbvoms-3EM39rvD-_tomuLiepWKX_pVx8IN2IQxPkm8vNCcXcQOMBRcwL0WuKnxOdwjsMLnfgE0gSQtcRpi-J3j04BHPjTuy49v30FQNJzFN3ga0bOcmQfocPfNx1ejvLvwIXcREySv5bhmnijL6Jh7zqjxxCoPmnWQSDpRUy6U9NJZYp0yEWiOgOB-DMVOMUMfoq3QBP8YYeuZstbHya0ck4xaWVIjjTEVK7wqxhki6_nU01bXQ_-yH4qm1GBKDabUyZR6laGXaeI3DcxsAry4iuujgz39iYl3R3ufdzTL0HYPGZsGZRmRF-NPhvAaKjq6M5zRmOCb5VxXlMYtHi3kHz5hAuqbOcnQoxZll_0XlFaVLDIkElb-emh6-H4IT0_-teFTdLPlVQA18hnaWsyW_nlM1xZ2OzniT0w4L_w
link.rule.ids 315,783,787,1378,27936,27937,46306,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQKwGX8oYUKD4gblnFsePYx-XRLrC7QqilFRfL9jpQdeus9iEtnPgP_EN-CR4nu2VRhRDiFimxpYy_yYzjb75B6GmI2KCTlqUu50XKNLMp4Ca1mbQy5yXjkYw5GPLeEXtzUpy07YCgFqbRh1j_cAPPiN9rcHD4Ib3p5bwgKRRzthQtUgrSCQnldvB-Cn0cXr6_0JJiFBKdditGZVPCIzIatmIF3eT4XDrtRuDahjVYApFSz4Itq6YJxmVZ6mbSG6PW_g00Xr1vQ1Y56yzmpmO__iYF-Z8MchPttNkt7jZwvIWuOH8bXR205_d30CSGxtWHKjzpli0R12PtR_hTpOb5evwlTICh5gJaW-C6wufQSmCJz90cmAJRXeLUhwg8w6ce95yv7ecf376Dpqgfhzt4EgC0mOq76Gj_1eGLXtr2fEhtgAVJKzGqmCPSMDoqXMGodsRIB7J1kEtaXtGCS-GENcRYqQPWLAHN_RCNrWSa3kNbvvbuAcLGMWmMC6tbWiYYNSKnWmitS5Y5mY0SRFYLqiaNtIf6ZUsUTKnAlApMqaIp1TJBz-LKrwfo6RlQ48pCHQ8P1AfG-8cHH58rlqC9DWisB-R5gF4IQQnCK6yo4NFwTKO9qxczVVIadnk0E394hHEocS5Igu43MLuYP6O0LEWWIB7B8tevprrvunC1-68Dn6BrvcNBX_VfD98-RNcbmgUwJR-hrfl04R6H7G1u9qJX_gQ0oTQU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtQwFLVQK1VseD_Co3iB2GUUjx3HXg6P6QDtqEKUVmws23GgmtYZzUMaWPEP_CFfgq-TmRJUIYTYjZTYUq7PzT2enHuM0NNQscEnLUtdn-cp08ymgJvUZtLKPi8Yj2LMgzEfHbE3J_lJq3-CXpjGH2LzhxtkRnxfQ4JPy6qb5DwnKfRytgotUgjSC3xym_FAhIEgvbuwkmIUeE67E6Oy6eARGQ07sZx2JT6XTtupW9uwBCvQUep5CGXVnIFxGUntct5YtIbX0WT9uI1WZdJbLkzPfv3NCfL_xOMGutZyWzxowHgTXXH-Fto5aL_e30bTWBjXr6lwp1u1MlyPtS_xpyjM8_XZlzABho4LONgC1xU-h4MEVvjcLUAnEL0lTn2ov3N86vHI-dp-_vHtOziK-rNwBU8DfJYzfQcdDV-9fzFK2xMfUhtAQdJKlBVzRBpGy9zljGpHjHRgWgdM0vKK5lwKJ6whxkodkGYJOO6HWmwl0_Qu2vK1d_cRNo5JY1xY3MIywagRfaqF1rpgmZNZmSCyXk81bYw91C8bohBKBaFUEEoVQ6lWCXoWF34zQM8mIIwrcnU83lMfGN8_3vv4XLEE7XaQsRnQ7wfkhQKUILyGigr5DB9ptHf1cq4KSsMej2biD7cwDg3OOUnQvQZlF_NnlBaFyBLEI1b--tHU4HAAvx7868AnaOfw5VDtvx6_fYiuNhoLkEk-QluL2dI9DtRtYXZjTv4EYwkyww
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transcriptional+expression+and+gelatinolytic+activity+of+matrix+metalloproteinases+in+Henoch-Schonlein+purpura&rft.jtitle=Acta+p%C3%A6diatrica+%28Oslo%29&rft.au=MAHAJAN%2C+N&rft.au=BISHT%2C+D&rft.au=DHAWAN%2C+V&rft.au=SINGH%2C+S&rft.date=2010-08-01&rft.pub=Blackwell&rft.issn=0803-5253&rft.eissn=1651-2227&rft.volume=99&rft.issue=8&rft.spage=1248&rft.epage=1252&rft_id=info:doi/10.1111%2Fj.1651-2227.2010.01781.x&rft.externalDBID=n%2Fa&rft.externalDocID=22946876
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0803-5253&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0803-5253&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0803-5253&client=summon